198 related articles for article (PubMed ID: 12169743)
1. Moving from CFC aerosol to HFA aerosol or dry powder inhalers: what do patients think?
Hartung TK; Allbutt H; Dewar M; Innes JA; Crompton GK
Respiration; 2002; 69(4):314-9. PubMed ID: 12169743
[TBL] [Abstract][Full Text] [Related]
2. Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study.
Houghton CM; Langley SJ; Singh SD; Holden J; Monici Preti AP; Acerbi D; Poli G; Woodcock A
Br J Clin Pharmacol; 2004 Oct; 58(4):359-66. PubMed ID: 15373928
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the safety of drug delivery via HFA- and CFC-metered dose inhalers in CAO.
Huchon G; Hofbauer P; Cannizzaro G; Iacono P; Wald F
Eur Respir J; 2000 Apr; 15(4):663-9. PubMed ID: 10780756
[TBL] [Abstract][Full Text] [Related]
4. Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
Boccuzzi SJ; Wogen J; Roehm JB
Clin Ther; 2000 Feb; 22(2):237-47. PubMed ID: 10743983
[TBL] [Abstract][Full Text] [Related]
5. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.
Bhattacharya A; Bhargava S; Singh V; Talwar D; Whig J; Rebello J; Purandare S; Gogtay J
Int J Chron Obstruct Pulmon Dis; 2016; 11():1469-76. PubMed ID: 27418820
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of chlorofluorocarbon and hydrofluoroalkane metered-dose inhaler formulations of beclomethasone dipropionate.
Lipworth BJ; Jackson CM
Br J Clin Pharmacol; 1999 Dec; 48(6):866-8. PubMed ID: 10594492
[TBL] [Abstract][Full Text] [Related]
9. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone.
Leach CL; Davidson PJ; Boudreau RJ
Eur Respir J; 1998 Dec; 12(6):1346-53. PubMed ID: 9877489
[TBL] [Abstract][Full Text] [Related]
10. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
Barnes N; Price D; Colice G; Chisholm A; Dorinsky P; Hillyer EV; Burden A; Lee AJ; Martin RJ; Roche N; von Ziegenweidt J; Israel E
Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
[TBL] [Abstract][Full Text] [Related]
11. Switching patients with asthma from chlorofluorocarbon (CFC) albuterol to hydrofluoroalkane-134a (HFA) albuterol.
Bronsky E; Ekholm BP; Klinger NM; Colice GL
J Asthma; 1999; 36(1):107-14. PubMed ID: 10077140
[TBL] [Abstract][Full Text] [Related]
12. Medical aerosol propellant interference with infrared anaesthetic gas monitors.
Levin PD; Levin D; Avidan A
Br J Anaesth; 2004 Jun; 92(6):865-9. PubMed ID: 15121726
[TBL] [Abstract][Full Text] [Related]
13. The chlorofluorocarbon to hydrofluoroalkane transition: the effect on pressurized metered dose inhaler suspension stability.
Brindley A
J Allergy Clin Immunol; 1999 Dec; 104(6):S221-6. PubMed ID: 10588978
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
[TBL] [Abstract][Full Text] [Related]
15. Clinical comparability between the CFC and HFA budesonide pressurised metered-dose inhalers in paediatric patients with asthma: a randomised controlled trial.
Escribano A; Tutuncu A; Löhr I; Carlholm M; Polanowski T
Curr Med Res Opin; 2006 Jun; 22(6):1085-92. PubMed ID: 16846541
[TBL] [Abstract][Full Text] [Related]
16. Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants.
Richards J; Hirst P; Pitcairn G; Mahashabde S; Abramowitz W; Nolting A; Newman SP
J Aerosol Med; 2001; 14(2):197-208. PubMed ID: 11681651
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G
Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007
[TBL] [Abstract][Full Text] [Related]
18. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
Peyron ID; Britto IL; Benissan LB; Tardieu BZ
Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
[TBL] [Abstract][Full Text] [Related]
19. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
Wolthers OD; Walters EG
Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
[TBL] [Abstract][Full Text] [Related]
20. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
Dusser D; Vicaut E; Lefrançois G;
Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
